You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 107 No. 8, August 1989 TABLE OF CONTENTS
  Archives
  •  Online Features
  CLINICAL SCIENCES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (88)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Epidemiology of Ocular Herpes Simplex

Incidence in Rochester, Minn, 1950 Through 1982

Thomas J. Liesegang, MD; L. Joseph Melton III, MD; Peter J. Daly, MD; Duane M. Ilstrup, MS

Arch Ophthalmol. 1989;107(8):1155-1159.


Abstract

• Over the period 1950 through 1982, 122 Rochester, Minn residents had their first episode of ocular herpes simplex virus infection, for an age- and sex-adjusted incidence of 8.4 new cases per 100000 person-years (95% confidence intervals [CI], 6.9 to 9.9 cases). These initial episodes involved lid or conjunctiva in 54%, superficial cornea in 63%, deeper cornea in 6%, and uveitis in 4%. An additional 29 residents had episodes of ocular herpes other than their first. Altogether, these 151 residents had 294 episodes of ocular herpes simplex infection, for an adjusted incidence of 20.7 episodes per 100000 person-years (95% CI, 18.3 to 23.1 episodes). Age-adjusted rates by sex were comparable. There were no seasonal trends in incidence, but rates increased with time. On January 1, 1980, the prevalence of a history of ocular herpes simplex infection was 149 per 100000 population (95% CI, 115 to 183).



Author Affiliations

From the Departments of Ophthalmology (Dr Liesegang) and Health Science Research (Drs Melton and Daly and Mr Ilstrup), Mayo Clinic and Foundation, Rochester, Minn.


Footnotes

Accepted for publication February 27, 1989.

Portions of this work were submitted as a candidate thesis for membership in the American Ophthalmological Society and accepted by the committee on theses.

Reprint requests to the Division of Ophthalmology, Mayo Clinic Jacksonville, 4500 San Pablo Rd, Jacksonville, FL 32224 (Dr Liesegang).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Role of Nectin-1, HVEM, and PILR-{alpha} in HSV-2 Entry into Human Retinal Pigment Epithelial Cells
Shukla et al.
IOVS 2009;50:2878-2887.
ABSTRACT | FULL TEXT  

Role for 3-o-sulfated heparan sulfate as the receptor for herpes simplex virus type 1 entry into primary human corneal fibroblasts.
Tiwari et al.
J. Virol. 2006;80:8970-8980.
ABSTRACT | FULL TEXT  

Conjunctival dendrite in a case of primary herpes simplex infection
Sridhar et al.
Br J Ophthalmol 2004;88:590-591.
FULL TEXT  

The bovine herpesvirus-1 LR ORF2 is critical for this gene's ability to restore the high wild-type reactivation phenotype to a herpes simplex virus-1 LAT null mutant
Mott et al.
J. Gen. Virol. 2003;84:2975-2985.
ABSTRACT | FULL TEXT  

HSV1 Latency Sites after Inoculation in the Lip: Assessment of their Localization and Connections to the Eye
Labetoulle et al.
IOVS 2003;44:217-225.
ABSTRACT | FULL TEXT  

Prevention of Herpes Simplex Virus Eye Disease: A Cost-effectiveness Analysis
Lairson et al.
Arch Ophthalmol 2003;121:108-112.
ABSTRACT | FULL TEXT  

Herpes Simplex Virus Type 1 Evades the Effects of Antibody and Complement In Vivo
Lubinski et al.
J. Virol. 2002;76:9232-9241.
ABSTRACT | FULL TEXT  

The outcome of corneal grafting in patients with stromal keratitis of herpetic and non-herpetic origin
Halberstadt et al.
Br J Ophthalmol 2002;86:646-652.
ABSTRACT | FULL TEXT  

Herpes Simplex Virus Type 1 Entry Is Inhibited by the Cobalt Chelate Complex CTC-96
Schwartz et al.
J. Virol. 2001;75:4117-4128.
ABSTRACT | FULL TEXT  

Psychological Stress and Other Potential Triggers for Recurrences of Herpes Simplex Virus Eye Infections
Herpetic Eye Disease Study Group
Arch Ophthalmol 2000;118:1617-1625.
ABSTRACT | FULL TEXT  

The Spread of Herpes Simplex Virus Type 1 from Trigeminal Neurons to the Murine Cornea: an Immunoelectron Microscopy Study
Ohara et al.
J. Virol. 2000;74:4776-4786.
ABSTRACT | FULL TEXT  

Diagnosis of viral and chlamydial keratoconjunctivitis: which laboratory test?
ELNIFRO et al.
Br J Ophthalmol 1999;83:622-627.
FULL TEXT  

Oral Acyclovir After Penetrating Keratoplasty for Herpes Simplex Keratitis
Tambasco et al.
Arch Ophthalmol 1999;117:445-449.
ABSTRACT | FULL TEXT  

Oral Acyclovir Suppresses Recurrent Epithelial and Stromal Herpes Simplex
Langston
Arch Ophthalmol 1999;117:391-392.
FULL TEXT  

Acyclovir for the Prevention of Recurrent Herpes Simplex Virus Eye Disease
Wilhelmus et al.
NEJM 1998;339:300-306.
ABSTRACT | FULL TEXT  

Acyclovir for Recurrent Herpes Simplex Virus Ocular Disease
Jabs
NEJM 1998;339:340-341.
FULL TEXT  

A Controlled Trial of Oral Acyclovir for the Prevention of Stromal Keratitis or Iritis in Patients With Herpes Simplex Virus Epithelial Keratitis: The Epithelial Keratitis Trial
The Herpetic Eye Disease Study Group
Arch Ophthalmol 1997;115:703-712.
ABSTRACT  

Epidemiology of Ocular Herpes Simplex: Natural History in Rochester, Minn, 1950 Through 1982
Liesegang
Arch Ophthalmol 1989;107:1160-1165.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.